Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy.

In this second review, we describe the main morphological events which accompany the development of the fetoplacental vascular system throughout normal human pregnancy and summarize findings on the expression of angiogenic growth factors and their receptors. Fetoplacental vasculogenesis starts at day 21 after conception by formation of haemangioblastic cords. In the following phase of branching angiogenesis (day 32 to week 25 post conception), haemangioblastic cords develop into a richly branched villous capillary bed with low fetoplacental blood flow impedance. This period is characterized by high placental levels of VEGF but moderate PlGF expression. In week 15, large centrally located villi show regression of peripheral capillary nets. In parallel, some remaining central capillaries acquire a tunica media and transform into arteries and veins. Beginning at about week 25 in the newly formed peripheral villi, angiogenesis switches from branching to non-branching and this period is accompanied by a steep drop in VEGF and a slower decline in PlGF expression. As a consequence of this switch, long poorly branched capillary loops are formed in the periphery of the fetoplacental vascular trees. These increase fetoplacental impedance but blood flow still increases due to rising fetal blood pressure. The possible interactions between (a). the biphasic development of intraplacental oxygen tensions, (b). changes in VEGF and PlGF levels and (c). developing vascular geometry are discussed. Special attention is given to the obvious discrepancy between sudden elevation of intervillous oxygen tensions which is not coincident with the appearance of angiogenic growth factor peaks and the switch from branching to non-branching angiogenesis. Finally, we deal with methods of quantifying aspects of angiogenesis in the villous vascular system and summarize the main findings during uncomplicated human pregnancy.

[1]  D. Charnock-Jones,et al.  VEGF mRNA levels in placentae from pregnancies complicated by pre‐eclampsia , 1996, British journal of obstetrics and gynaecology.

[2]  P Kaufmann,et al.  Classification of human placental stem villi: Review of structural and functional aspects , 1997, Microscopy research and technique.

[3]  G. Zambruno,et al.  Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. , 2002, Journal of cell science.

[4]  D. Charnock-Jones,et al.  Expression of mRNA for vascular endothelial growth factor in human placenta. , 1993, Journal of reproduction and fertility.

[5]  S. Lye,et al.  Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. , 1994, Placenta.

[6]  Mojmir R Tarek,et al.  A novel mechanism of capillary growth in the rat pulmonary microcirculation , 1990, The Anatomical record.

[7]  D. Ginzinger,et al.  Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. , 2002, The Journal of clinical endocrinology and metabolism.

[8]  J. Jiang,et al.  Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[9]  P. Kaufmann,et al.  Classification of human placental villi , 1979, Cell and Tissue Research.

[10]  R. Leiser,et al.  The fetal vascularisation of term human placental villi , 2004, Anatomy and Embryology.

[11]  G. Burton,et al.  Stereological evaluation of vascular adaptations in human placental villi to differing forms of hypoxic stress. , 1996, Placenta.

[12]  J. Kingdom,et al.  Oxygen and placental villous development: origins of fetal hypoxia. , 1997, Placenta.

[13]  N. Arts Investigations on the vascular system of the placenta. II. The maternal vascular system. , 1961, American journal of obstetrics and gynecology.

[14]  H. Augustin Tubes, branches, and pillars: the many ways of forming a new vasculature. , 2001, Circulation research.

[15]  J. Nyengaard The quantitative development of glomerular capillaries in rats with special reference to unbiased stereological estimates of their number and sizes. , 1993, Microvascular research.

[16]  R. Brace,et al.  Cellular localization of vascular endothelial growth factor in ovine placenta and fetal membranes. , 2000, Placenta.

[17]  P. Boyd Quantitative structure of the normal human placenta from 10 weeks of gestation to term. , 1984, Early human development.

[18]  J. Kingdom,et al.  Increased fetoplacental angiogenesis during first trimester in anaemic women , 1998, The Lancet.

[19]  E. Keshet,et al.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Wada,et al.  Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. , 2002, Human pathology.

[21]  D. Redmer,et al.  Angiogenesis in the Placenta1 , 2001 .

[22]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[23]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[24]  R. Resnik Intrauterine growth restriction. , 2002, Obstetrics and gynecology.

[25]  M. Knoth Ultrastructure of chorionic villi from a four-somite human embryo. , 1968, Journal of ultrastructure research.

[26]  J. Kingdom,et al.  Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. , 1999, Obstetrics and gynecology.

[27]  R. Leiser,et al.  Three-Dimensional Representation of the Fetal Vessel System in the Human Placenta , 1988 .

[28]  K. Benirschke,et al.  Pathology of the Human Placenta , 1992, Springer New York.

[29]  P. Kaufmann,et al.  Classification of human placental villi , 1979, Cell and Tissue Research.

[30]  T. H. Wang,et al.  Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. , 1997, Placenta.

[31]  T M Mayhew,et al.  Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. , 2004, Placenta.

[32]  P. Kaufmann,et al.  The development of the human placental villous tree , 2004, Anatomy and Embryology.

[33]  F. Teasdale Gestational changes in the functional structure of the human placenta in relation to fetal growth: a morphometric study. , 1980, American journal of obstetrics and gynecology.

[34]  Ziegler Sf,et al.  Molecular Cloning and Characterization of a Novel Receptor Protein Tyrosine Kinase From Human Placenta , 1993 .

[35]  M. Seif,et al.  Expression of the vascular endothelial growth factor receptor, KDR, in human placenta. , 1996, Journal of anatomy.

[36]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.

[37]  T. Noda,et al.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Charnock-Jones,et al.  Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. , 1999, Molecular endocrinology.

[39]  B. Huppertz,et al.  Villous sprouting: fundamental mechanisms of human placental development. , 2000, Human reproduction update.

[40]  L. Myatt,et al.  Control of vascular resistance in the human placenta. , 1992, Placenta.

[41]  A. N. Corps,et al.  A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. , 1998, Biology of reproduction.

[42]  W. Aherne,et al.  Quantitative aspects of placental structure. , 1966, The Journal of pathology and bacteriology.

[43]  E. Jauniaux,et al.  Oxygen Measurements in Endometrial and Trophoblastic Tissues During Early Pregnancy , 1992, Obstetrics and gynecology.

[44]  P. Mcparland,et al.  Review article: Doppler blood flow in pregnancy , 1988 .

[45]  R. Gardner,et al.  Vascularization in the murine allantois occurs by vasculogenesis without accompanying erythropoiesis. , 1998, Development.

[46]  T. Mayhew,et al.  Changes in oxygen diffusive conductances of human placentae during gestation (10-41 weeks) are commensurate with the gain in fetal weight. , 1993, Placenta.

[47]  D. Charnock-Jones,et al.  Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey. , 2000, Molecular human reproduction.

[48]  D. Charnock-Jones,et al.  Placental vessel adaptation during gestation and to high altitude: changes in diameter and perivascular cell coverage. , 2002, Placenta.

[49]  C. Geisen,et al.  Alterations of the fetal capillary bed in the guinea pig placenta following long-term hypoxia. , 1990, Advances in experimental medicine and biology.

[50]  D. Charnock-Jones,et al.  Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs. , 2001, Reproduction.

[51]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[52]  R. Demir,et al.  Placental villous stroma as a model system for myofibroblast differentiation , 1996, Histochemistry and Cell Biology.

[53]  S A Tschanz,et al.  Intussusceptive angiogenesis: its role in embryonic vascular network formation. , 2000, Circulation research.

[54]  C. Elcock,et al.  Angiogenesis and the placental environment. , 1995, Placenta.

[55]  P. Taylor,et al.  J Soc Gynecol Investig , 2005 .

[56]  C H Rodeck,et al.  Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. , 1986, Fetal therapy.

[57]  T. Schiebler,et al.  Über den Feinbau der Meerschweinchenplacenta während der Entwicklung , 1970, Zeitschrift für Anatomie und Entwicklungsgeschichte.

[58]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[59]  A. Ahmed,et al.  Localization of mRNA for basic fibroblast growth factor in human placenta. , 1994, Growth factors.

[60]  D. Charnock-Jones,et al.  The Regulation and Localization of Angiopoietin-1, -2, and Their Receptor Tie2 in Normal and Pathologic Human Placentae , 2001, Molecular medicine.

[61]  V. Dantzer,et al.  Co-localization of vascular endothelial growth factor and its two receptors flt-1 and kdr in the mink placenta. , 2001, Placenta.

[62]  J. Kingdom,et al.  The 'reference trap' revisited: examples of the dangers in using ratios to describe fetoplacental angiogenesis and trophoblast turnover. , 2003, Placenta.

[63]  D. Rushton,et al.  Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. , 1995, Growth factors.

[64]  J. Flanagan,et al.  Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.

[65]  Shakil Ahmad,et al.  Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review. , 2000, Placenta.

[66]  H. Richard Morphogenesis of Endothelium , 2002 .

[67]  T. Mayhew,et al.  Quantitative description of the elaboration and maturation of villi from 10 weeks of gestation to term. , 1992, Placenta.

[68]  H. Granger,et al.  Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[69]  G. Martiny-Baron,et al.  VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. , 1996, Developmental biology.

[70]  K. Alitalo,et al.  Expression of vascular endothelial growth factor and placenta growth factor in human placenta. , 1997, Biology of reproduction.

[71]  J. Peng,et al.  Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. , 1999, Development.

[72]  R. Ferriani,et al.  Colocalization of acidic and basic fibroblast growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. , 1994, Growth factors.

[73]  Thomas N. Sato,et al.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.

[74]  R. Demir,et al.  Fetal Vasculogenesis and Angiogenesis in Human Placental Villi , 1989 .

[75]  G. Semenza,et al.  HIF-1, O2, and the 3 PHDs How Animal Cells Signal Hypoxia to the Nucleus , 2001, Cell.

[76]  A. D. Smith,et al.  Placental anatomy and diffusing capacity in guinea pigs following long-term maternal hypoxia. , 1984, Placenta.

[77]  C. Sibley,et al.  Pathogenesis of intrauterine growth restriction (IUGR)-conclusions derived from a European Union Biomed 2 Concerted Action project 'Importance of Oxygen Supply in Intrauterine Growth Restricted Pregnancies'-a workshop report. , 2002, Placenta.

[78]  T. Mayhew Changes in fetal capillaries during preplacental hypoxia: growth, shape remodelling and villous capillarization in placentae from high-altitude pregnancies. , 2003, Placenta.

[79]  Jiří Janáček,et al.  Topological Properties and Spatial Organization of Villous Capillaries in Normal and Diabetic Placentas , 2002, Journal of Vascular Research.

[80]  J. Bertram,et al.  Angiogenesis occurs by vessel elongation in proliferative phase human endometrium. , 2002, Human reproduction.

[81]  T M Mayhew,et al.  Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. , 2004, Placenta.

[82]  G. Desoye,et al.  Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. , 2003, European journal of cell biology.

[83]  T. Mayhew Enhanced fetoplacental angiogenesis in pre-gestational diabetes mellitus: the extra growth is exclusively longitudinal and not accompanied by microvascular remodelling , 2002, Diabetologia.

[84]  R. Leiser,et al.  The fetal vascularisation of term human placental villi , 1985, Anatomy and Embryology.

[85]  L. Cantley,et al.  Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2 , 1996, Cell.

[86]  E. Jauniaux,et al.  Evaluation of respiratory gases and acid-base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks' gestation. , 2001, American journal of obstetrics and gynecology.

[87]  E. Dempsey The development of capillaries in the villi of early human placentas. , 1972, The American journal of anatomy.

[88]  L. Leach,et al.  Isolation of endothelial cells from human term placental villi using immunomagnetic beads. , 1994, Placenta.

[89]  J. Nyengaard,et al.  The number of glomerular capillaries estimated by an unbiased and efficient stereological method , 1993, Journal of microscopy.

[90]  J. Wolff,et al.  “Seamless” endothelial cells of blood capillaries , 2004, Cell and Tissue Research.

[91]  S. Dey,et al.  Expression of vascular endothelial growth factor (VEGF) and VEGF-receptor messenger ribonucleic acids in the peri-implantation rabbit uterus. , 1997, Biology of reproduction.

[92]  D. Charnock-Jones,et al.  Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. , 1996, Human reproduction.

[93]  N. Kinukawa,et al.  Immunohistochemical localization of vascular endothelial growth factor in the human placenta. , 1996, Placenta.

[94]  M. Whittle,et al.  Localisation of placenta growth factor (PIGF) in human term placenta. , 1996, Growth factors.

[95]  T. Mayhew Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. , 2002, Placenta.

[96]  Judah Folkman,et al.  Angiogenesis in vitro , 1980, Nature.

[97]  B. King Ultrastructural differentiation of stromal and vascular components in early macaque placental villi. , 1987, The American journal of anatomy.

[98]  V. Dantzer,et al.  Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus. , 1996, Placenta.

[99]  Till Acker,et al.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.

[100]  Christoph Dehio,et al.  Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 , 2003, Nature Medicine.